Intrathecal Infusion in Cancer Pain Surgery

Intrathecal drug delivery is an effective modality for managing refractory cancer pain and can significantly enhance patient quality of life. Early integration into the cancer care continuum, rather than reserving ITDD as a last resort, may provide superior symptom control. Careful patient selection, individualized pharmacologic regimens, and precise surgical technique are critical to minimizing complications and optimizing outcomes. Further research is needed to refine drug combinations, improve device technology, and define best practices for early intervention strategies.